FocusVirus-Associated Disease

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

See allHide authors and affiliations

Science Translational Medicine  02 Nov 2011:
Vol. 3, Issue 107, pp. 107fs7
DOI: 10.1126/scitranslmed.3002878


Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

View Full Text

Stay Connected to Science Translational Medicine